User contributions
Jump to navigation
Jump to search
- 02:36, 16 December 2021 diff hist -38 m Gastrointestinal stromal tumor Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:36, 16 December 2021 diff hist -6 m Breast cancer, PIK3CA-mutated Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:36, 16 December 2021 diff hist -74 m Small cell lung cancer - historical Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:35, 16 December 2021 diff hist -2 m Aplastic anemia Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:35, 16 December 2021 diff hist -28 m Small cell lung cancer - null regimens Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:35, 16 December 2021 diff hist -120 m Rectal cancer Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:35, 16 December 2021 diff hist -2 m Peripheral T-cell lymphoma - historical Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:34, 16 December 2021 diff hist -4 m Leiomyosarcoma - null regimens Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:34, 16 December 2021 diff hist -4 m Pancreatic cancer, BRCA-mutated Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:33, 16 December 2021 diff hist -14 m Soft tissue sarcoma - null regimens Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:33, 16 December 2021 diff hist -12 m Multiple myeloma, induction Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:33, 16 December 2021 diff hist -16 m Pancreatic NET Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:33, 16 December 2021 diff hist -52 m Anaplastic glioma Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:33, 16 December 2021 diff hist -4 m Medulloblastoma Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:32, 16 December 2021 diff hist -8 m Endometrial cancer Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:32, 16 December 2021 diff hist -12 m Renal cell carcinoma - historical Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:30, 16 December 2021 diff hist -96 m Glioblastoma Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:30, 16 December 2021 diff hist -6 m Multiple myeloma, consolidation and maintenance Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:30, 16 December 2021 diff hist -20 m Prostate cancer - historical Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:29, 16 December 2021 diff hist -2 m Cutaneous squamous cell carcinoma Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:29, 16 December 2021 diff hist -112 m Non-small cell lung cancer, EGFR-mutated Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:28, 16 December 2021 diff hist -122 m Melanoma Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:28, 16 December 2021 diff hist -14 m Kaposi sarcoma Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:27, 16 December 2021 diff hist -314 m Prostate cancer Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:27, 16 December 2021 diff hist -2 m Desmoid tumor Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:27, 16 December 2021 diff hist -4 m Ewing sarcoma Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:27, 16 December 2021 diff hist -98 m Hepatocellular carcinoma Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:27, 16 December 2021 diff hist -38 m Melanoma, BRAF-mutated Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:27, 16 December 2021 diff hist -2 m Gallbladder cancer - null regimens Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:26, 16 December 2021 diff hist -184 m Breast cancer - historical Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:25, 16 December 2021 diff hist -4 m Melanoma - null regimens Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:25, 16 December 2021 diff hist -58 m Melanoma - historical Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:25, 16 December 2021 diff hist -194 m Pancreatic cancer Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:24, 16 December 2021 diff hist -18 m Leiomyosarcoma Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:24, 16 December 2021 diff hist -4 m Wilms tumor Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:24, 16 December 2021 diff hist -4 m Melanoma, NRAS-mutated Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:24, 16 December 2021 diff hist -56 m Soft tissue sarcoma Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:22, 16 December 2021 diff hist -34 m Esophageal squamous cell carcinoma Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:22, 16 December 2021 diff hist -22 m Peripheral T-cell lymphoma Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:22, 16 December 2021 diff hist -20 m Diffuse large B-cell lymphoma - historical Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:21, 16 December 2021 diff hist -50 m Acute promyelocytic leukemia Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:21, 16 December 2021 diff hist -62 m Breast cancer - null regimens Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:21, 16 December 2021 diff hist -22 m Head and neck cancer Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:20, 16 December 2021 diff hist -2 m Beta thalassemia Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:19, 16 December 2021 diff hist -4 m Acute myeloid leukemia, NPM1-mutated Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:19, 16 December 2021 diff hist -26 m Acute myeloid leukemia, pediatric Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:18, 16 December 2021 diff hist -24 m Rectal cancer - null regimens Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:18, 16 December 2021 diff hist -6 m Pancreatic cancer - historical Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:18, 16 December 2021 diff hist -8 m Hereditary hemorrhagic telangiectasia Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:18, 16 December 2021 diff hist -144 m Venous thromboembolism Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"